References and Notes
<A NAME="RU09710ST-1">1</A>
Kinoshita H.
Ihoriya A.
Ju-ichi M.
Kimachi T.
Synlett
2010,
2330
Alcoholysis:
<A NAME="RU09710ST-2A">2a</A>
Tamami B.
Iranpoor N.
Razaei R.
Synth. Commun.
2004,
34:
2789
<A NAME="RU09710ST-2B">2b</A>
Iranpoor N.
Salehi P.
Synthesis
1994,
1152
<A NAME="RU09710ST-2C">2c</A>
Surendra K.
Krishnaveni NS.
Nageswar YVD.
Rao KR.
J.
Org. Chem.
2003,
68:
4994
Aminolysis:
<A NAME="RU09710ST-2D">2d</A>
Murai T.
Sano H.
Kawai H.
Aso H.
Shibahara F.
J. Org.
Chem.
2005,
70:
8148
<A NAME="RU09710ST-2E">2e</A>
Mirkhani V.
Tangestaninejad S.
Yadollahi B.
Alipanah L.
Catal. Lett.
2005,
101:
93
<A NAME="RU09710ST-2F">2f</A>
Lupi V.
Albanese D.
Landini D.
Scaletti D.
Penso M.
Tetrahedron
2004,
60:
11709
<A NAME="RU09710ST-2G">2g</A>
Sundararajan G.
Vijayakrishna K.
Varghese B.
Tetrahedron
Lett.
2004,
45:
8253
Azidolysis:
<A NAME="RU09710ST-2H">2h</A>
Marie J.-C.
Courillon C.
Malarcia M.
Synlett
2002,
553:
Reductive ring opening
<A NAME="RU09710ST-2I">2i</A>
Ley SV.
Mitchell C.
Pears D.
Ramarao C.
Yu J.-Q.
Zhou W.
Org. Lett.
2003,
5:
4665
Lewis acid catalyzed ring opening of epoxides:
<A NAME="RU09710ST-2J">2j</A>
Blum SA.
Rivera VA.
Ruck RT.
Michael FE.
Bergman RG.
Organometallics
2005,
24:
1647
<A NAME="RU09710ST-2K">2k</A>
Asandei AD.
Moran IW.
J.
Am. Chem. Soc.
2004,
126:
15932
<A NAME="RU09710ST-3">3</A>
Ley SV.
Mitchell C.
Pears D.
Ramarao C.
Yu J.-Q.
Zhou W.
Org. Lett.
2003,
5:
4665
<A NAME="RU09710ST-4">4</A>
Blasio ND.
Lopardo MT.
Lupattelli P.
Eur.
J. Org. Chem.
2009,
938
<A NAME="RU09710ST-5A">5a</A>
Shirota O.
Pathak V.
Sekita S.
Satake M.
Nagashima Y.
Hirayama Y.
Hakamata Y.
Hayashi T.
J.
Nat. Prod.
2003,
66:
1128
<A NAME="RU09710ST-5B">5b</A>
Watanabe M.
Date M.
Kawanishi K.
Hori T.
Furukawa S.
Chem.
Pharm. Bull.
1991,
39:
41
<A NAME="RU09710ST-5C">5c</A>
Watanabe M.
Kawanishi K.
Akiyoshi R.
Furukawa S.
Chem. Pharm. Bull.
1991,
39:
3123
<A NAME="RU09710ST-6A">6a</A>
Kimachi T.
Kinoshita H.
Kusaka K.
Takeuchi Y.
Aoe M.
Ju-ichi M.
Synlett
2005,
842
<A NAME="RU09710ST-6B">6b</A>
All new compounds show
analytical and spectral (¹H NMR, ¹³C NMR,
HRMS) data consistent with the depicted structure.
<A NAME="RU09710ST-7">7</A>
Typical Procedure
for the Reductive Ring-Opening Reaction of the Epoxides 4-11
and Deuterated Epoxides (4-
d
-11-
d
)
Pd(0) catalyst [Pd(0)EnCatTM,
50 mg, 0.02 mmol] was added to a solution of the epoxide
(0.38 mmol) in EtOAc (0.75 mL) at r.t. under argon atmosphere. The
mixture was cooled to 0 ˚C, Et3N (0.28
mL, 4 mmol) and formic acid (0.07 mL, 4 mmoL) were added. After
5 h stirring at r.t., the mixture was worked up as follows. The
resulting Pd(0) was filtered off, then filtrate was concentrated
under reduced pressure. The remaining residue was purified by flash
chromatography to afford the product.
¹
H NMR Spectra of the Ring-Opened Products 12-21
Product 12: ¹H NMR (400 MHz,
CDCl3): δ = 1.65 (s, 1 H), 2.35 (s,
3 H), 2.91-3.06 (m, 2 H), 4.85-4.89 (m, 1 H),
7.10-7.36 (m, 9 H).
Product 13: ¹H
NMR (400 MHz, CDCl3): δ = 1.90 (s,
1 H), 3.00 (m, 2 H), 3.80 (s, 3 H), 4.84 (dd, 1 H, J = 5.9,
7.3 Hz), 6.85-6.89 (m, 2 H), 7.16-7.34 (m, 7 H).
Product 14: ¹H NMR (500 MHz,
CDCl3): δ = 1.11 (m, 3 H), 1.22 (m,
3 H), 2.97 (dd, 1 H, J = 8.2,
13.7 Hz), 3.03 (dd, 1 H, J = 5.0,
13.7 Hz), 3.25 (m, 2 H), 3.53 (m, 2 H), 4.91 (dd, 1 H, J = 5.0, 8.2
Hz), 7.16-7.36 (m, 9 H).
Product 15: ¹H
NMR (400 MHz, CDCl3): δ = 1.60 (s,
9 H), 2.97 (dd, 1 H, J = 8.4,
13.9 Hz), 3.04 (dd, 1 H, J = 4.8,
13.9 Hz), 4.95 (m, 1 H), 7.16-7.18 (m, 2 H), 7.22-7.32
(m, 3 H), 7.38 (d, 2 H, J = 8.4
Hz), 7.95 (d, 2 H, J = 8.4
Hz).
Product 16: ¹H
NMR (400 MHz, CDCl3): δ = 1.32 (s,
9 H), 1.89 (s, 1 H), 2.97 (dd, 1 H, J = 10.2,
13.5 Hz), 3.04 (dd, 1 H, J = 4.4,
13.5 Hz), 4.86 (m, 1 H), 7.20-7.30 (m, 5 H), 7.31 (d, 2
H, J = 8.4
Hz), 7.37 (d, 2 H, J = 8.4
Hz).
Product 17: ¹H
NMR (400 MHz, CDCl3): δ = 2.1 (d, 1
H, J = 3.0
Hz), 2.94 (dd, 1 H, J = 8.4,
13.5 Hz), 3.03 (dd, 1 H, J = 4.8,
13.5 Hz), 4.95 (m, 1 H), 7.14-7.36 (m, 5 H), 7.43 (d, 2
H, J = 8.0
Hz), 7.61 (d, 2 H, J = 8.0
Hz).
Product 18: ¹H
NMR (400 MHz, CDCl3): δ = 1.98 (m,
1 H), 3.05 (m, 1 H), 3.13 (m, 1 H), 4.90 (m, 1 H), 7.24-7.36
(m, 5 H), 7.27 (d, 2 H, J = 8.3
Hz), 7.54 (d, 2 H, J = 8.3
Hz).
Product 19: ¹H
NMR (500 MHz, CDCl3): δ = 3.07 (d,
2 H, J = 6.4
Hz), 5.00 (t, 1 H, J = 6.4
Hz), 7.27 (d, 2 H, J = 8.2 Hz),
7.42 (d, 2 H, J = 8.2
Hz), 7.57 (d, 2 H, J = 8.2
Hz), 7.60 (d, 2 H, J = 8.2
Hz).
Product 20: ¹H
NMR (400 MHz, CDCl3): δ = 2.89 (dd,
1 H, J = 8.4,
13.9 Hz), 2.99 (dd, 1 H, J = 4.8,
13.5 Hz), 3.79 (s, 3 H), 4.91 (m, 1 H), 6.84 (d, 2 H, J = 8.4 Hz),
7.08 (d, 2 H, J = 8.4
Hz), 7.45 (d, 2 H, J = 8.1
Hz), 7.59 (d, 2 H, J = 8.1 Hz).
Product 21: ¹H NMR (400 MHz,
CDCl3): δ = 3.04-3.08 (m, 2
H), 3.81 (s, 3 H), 4.86 (m, 1 H), 6.87 (d, 2 H, J = 8.8
Hz), 7.22-7.28 (m, 4 H), 7.52 (d, 2 H, J = 8.1
Hz).
¹
H NMR Spectra of Deuterated Ring-Opened Products 12-
d
-21-
d
Product 12-d: ¹H NMR (400 MHz,
CDCl3): δ = 2.34 (s, 3 H), 2.94-3.01
(m, 1 H), 4.83-4.85 (m, 1 H), 7.06-7.36 (m, 10 H).
Product 13-d: ¹H
NMR (400 MHz, CDCl3): δ = 3.00 (s,
2 H), 3.80 (s, 3 H), 6.87 (d, 2 H, J = 8.8
Hz), 7.26 (d, 2 H, J = 8.8 Hz),
7.16-7.30 (m, 5 H).
Product 14-d: ¹H NMR (400 MHz,
CDCl3): δ = 1.14 (m, 3 H), 1.22 (m,
3 H), 2.05 (s, 1 H), 3.02 (d, 1 H, J = 4.4
Hz), 3.27 (m, 2 H), 3.53 (m, 2 H), 4.92 (d, 1 H, J = 4.4
Hz), 7.17-7.38 (m, 9 H).
Product 15-d: ¹H NMR (400 MHz,
CDCl3): δ = 1.60 (s, 9 H), 1.99 (d,
1 H, J = 3.2
Hz), 3.02 (d, 1 H, J = 4.6
Hz), 4.95 (m, 1 H), 7.15-7.18 (m, 2 H), 7.22-7.32
(m, 3 H), 7.38 (d, 2 H, J = 8.2
Hz), 7.95 (d, 2 H, J = 8.2
Hz).
Product 16-d: ¹H
NMR (400 MHz, CDCl3): δ = 1.31 (s,
9 H), 1.89 (s, 1 H), 3.04 (d, 1 H, J = 4.4
Hz), 4.86 (d, 1 H, J = 4.4 Hz),
7.20-7.30 (m, 5 H), 7.31 (d, 2 H, J = 8.4
Hz), 7.37 (d, 2 H, J = 8.4
Hz).
Product 17-d: ¹H
NMR (400 MHz, CDCl3): δ = 2.07 (d,
1 H, J = 3.2
Hz), 3.01 (m, 1 H), 4.95 (m, 1 H), 7.27-7.40 (m, 5 H), 7.43
(d, 2 H, J = 8.3
Hz), 7.62 (d, 2 H, J = 8.3
Hz).
Product 18-d: ¹H
NMR (400 MHz, CDCl3): δ = 2.00 (br
s, 1 H), 3.05 (m, 1 H), 3.10 (m, 1 H), 7.37 (m, 5 H), 7.30 (d, 2
H, J = 8.3
Hz), 7.55 (d, 2 H, J = 8.3
Hz).
Product 19-d: ¹H
NMR (400 MHz, CDCl3): δ = 1.96 (s,
1 H), 3.07 (s, 2 H), 7.27 (d, 2 H, J = 8.1
Hz), 7.42 (d, 2 H, J = 8.1 Hz),
7.56-7.65 (m, 4 H).
Product 20-d: ¹H NMR (400 MHz,
CDCl3): δ = 1.98 (d, 1 H, J = 3.3 Hz),
2.98 (m, 1 H), 3.79 (s, 3 H), 4.91 (s, 1 H), 6.85 (d, 2 H, J = 8.1 Hz),
7.08 (d, 2 H, J = 8.1
Hz), 7.45 (d, 2 H, J = 8.4
Hz), 7.59 (d, 2 H, J = 8.4
Hz).
Product 21-d: ¹H
NMR (400 MHz, CDCl3): δ = 1.81 (s,
1 H), 3.06 (dd, 2 H, J = 13.5,
23.8 Hz), 3.81 (s, 3 H), 6.88 (d, 2 H, J = 8.8
Hz), 7.24 (d, 2 H, J = 8.8
Hz), 7.27 (d, 2 H, J = 8.1 Hz),
7.53 (d, 2 H, J = 8.1
Hz).
<A NAME="RU09710ST-8">8</A>
Gaunt MJ.
Yu J.
Spencer JB.
J.
Org. Chem.
1998,
63:
4172